TY - JOUR
T1 - Muscle Biopsy Findings in Valosin-Containing Protein Multisystem Proteinopathy
AU - VCP International Study Group
AU - Schiava, Marianela
AU - Parkhurst, Yolande
AU - Henderson, Matthew
AU - Polvikoski, Tuomo
AU - Valtcheva, Manouela V.
AU - Nishino, Ichizo
AU - Inoue, Michio
AU - Nishimori, Yukako
AU - Saito, Yoshihiko
AU - Stojkovic, Tanya
AU - Villar-Quiles, Rocio N.
AU - Romero, Norma Beatriz
AU - Evangelista, Teresinha
AU - Malfatti, Edoardo
AU - Souvannanorath, Sarah
AU - Pegoraro, Elena
AU - Riguzzi, Pietro
AU - Monforte, Mauro
AU - Bortolani, Sara
AU - Torchia, Eleonora
AU - Sabatelli, Mario
AU - Tasca, Giorgio
AU - Straub, Volker
AU - Marini-Bettolo, Chiara
AU - Guglieri, Michela
AU - Cetin, Hakan
AU - Gelpi, Ellen
AU - Klotz, Sigrid
AU - De Bleecker, Jan L.
AU - Alonso-Jimenez, Alicia
AU - Baets, Jonathan
AU - De Ridder, Willem
AU - De Jonghe, Peter
AU - Claeys, Kristl G.
AU - Thal, Dietmar Rudolf
AU - Bevilacqua, Jorge A.
AU - Luo, Sushan
AU - Zhu, Wenhua
AU - Lin, Jie
AU - Papadimas, George
AU - Papadopoulos, Constantinos
AU - Zamba-Papanicolaou, Eleni
AU - Xirou, Sophia
AU - Pal, Endre
AU - Rodolico, Carmelo
AU - Kostera-Pruszczyk, Anna
AU - Kierdaszuk, Biruta
AU - Kaminska, Anna
AU - Muelas, Nuria
AU - Vilchez, Juan Jesus
AU - Domínguez-González, Cristina
AU - Hernandez-Lain, Aurelio
AU - Alonso-Perez, Jorge
AU - Nedkova-Hristova, Velina
AU - Aledo, Carlos
AU - Oldfors, Anders
AU - Badrising, Umesh A.
AU - Kushlaf, Hani
AU - Lloyd, Thomas E.
AU - Ikenaga, Chiseko
AU - Alfano, Lindsay N.
AU - Quinn, Colin C.
AU - Walk, David
AU - Vorgerd, Matthias
AU - Weihl, Conrad
AU - Olivé, Montse
AU - Diaz-Manera, Jordi
N1 - Publisher Copyright:
© 2025 The Author(s).
PY - 2025/8/1
Y1 - 2025/8/1
N2 - Background and Objectives Valosin Containing Protein-associated multisystem proteinopathy (VCP-MSP) is a progressive, autosomal dominant disorder caused by pathogenic variants in the VCP gene, resulting in a heterogeneous clinical presentation. Muscle biopsy findings are characteristic but not pathognomonic. This study aimed to comprehensively analyse VCP-related myopathology and explore correlations with clinical phenotypes, genetic variants, and disease progression. Methods Muscle biopsy images and data were collected retrospectively from adults (≥18 years) with pathogenic or likely pathogenic VCP variants enrolled in the VCP Multicentre International Study. Biopsy data were standardized using the “Common Data Elements for Muscle Biopsy Reporting.” Variations in biopsy findings were analysed by biopsy site, time from disease onset, the four most common VCP variants, and clinical phenotypes. Result A total of 112 muscle biopsies were included. Most individuals were male (66.0%). The mean age at biopsy was 53.3 years (SD 10.0), with a mean disease duration of 6.5 years (SD 4.5). The most frequent VCP variant was c.464G>A (p.Arg155His) (18.8%). The top clinical phenotypes were isolated myopathy (37.5%), myopathy with Paget disease of bone (17.9%), and myopathy with motor neuron involvement (13.4%). The vastus lateralis was the most common biopsy site (34.8%), and 91% were open biopsies. Histopathologic findings included atrophic fibres (87.5%), rimmed vacuoles (72.3%), endomysial fibrosis (58.0%), and protein aggregates (51.8%), primarily p62 (60.3%) and VCP (36.2%). Degeneration niches with fibrofatty replacement and atrophic fibres were seen in 33.3% of biopsies without frequency differences by clinical phenotypes. There were no differences in biopsy findings among the 4 most common VCP gene variants, except for the absence of degeneration niches in muscle biopsies of 12 patients with c.277C>T (p.Arg93Cys). MRI data from 30 patients showed fat pockets corresponding to these niches and STIR hyperintensity correlated with inflammatory infiltrates in 42.9%. Concordance between clinical phenotype, biopsy, and neurophysiology was observed in only 49.4% of cases, indicating significant heterogeneity. Discussion VCP-MSP muscle biopsies consistently show myopathic or mixed patterns with rimmed vacuoles and p62/VCP-positive inclusions, regardless of clinical phenotype, age, or progression. Some lack vacuoles, challenging diagnosis. Discrepancies between clinical, neurophysiology, and biopsy findings should prompt consideration of VCP-MSP to improve detection and management.
AB - Background and Objectives Valosin Containing Protein-associated multisystem proteinopathy (VCP-MSP) is a progressive, autosomal dominant disorder caused by pathogenic variants in the VCP gene, resulting in a heterogeneous clinical presentation. Muscle biopsy findings are characteristic but not pathognomonic. This study aimed to comprehensively analyse VCP-related myopathology and explore correlations with clinical phenotypes, genetic variants, and disease progression. Methods Muscle biopsy images and data were collected retrospectively from adults (≥18 years) with pathogenic or likely pathogenic VCP variants enrolled in the VCP Multicentre International Study. Biopsy data were standardized using the “Common Data Elements for Muscle Biopsy Reporting.” Variations in biopsy findings were analysed by biopsy site, time from disease onset, the four most common VCP variants, and clinical phenotypes. Result A total of 112 muscle biopsies were included. Most individuals were male (66.0%). The mean age at biopsy was 53.3 years (SD 10.0), with a mean disease duration of 6.5 years (SD 4.5). The most frequent VCP variant was c.464G>A (p.Arg155His) (18.8%). The top clinical phenotypes were isolated myopathy (37.5%), myopathy with Paget disease of bone (17.9%), and myopathy with motor neuron involvement (13.4%). The vastus lateralis was the most common biopsy site (34.8%), and 91% were open biopsies. Histopathologic findings included atrophic fibres (87.5%), rimmed vacuoles (72.3%), endomysial fibrosis (58.0%), and protein aggregates (51.8%), primarily p62 (60.3%) and VCP (36.2%). Degeneration niches with fibrofatty replacement and atrophic fibres were seen in 33.3% of biopsies without frequency differences by clinical phenotypes. There were no differences in biopsy findings among the 4 most common VCP gene variants, except for the absence of degeneration niches in muscle biopsies of 12 patients with c.277C>T (p.Arg93Cys). MRI data from 30 patients showed fat pockets corresponding to these niches and STIR hyperintensity correlated with inflammatory infiltrates in 42.9%. Concordance between clinical phenotype, biopsy, and neurophysiology was observed in only 49.4% of cases, indicating significant heterogeneity. Discussion VCP-MSP muscle biopsies consistently show myopathic or mixed patterns with rimmed vacuoles and p62/VCP-positive inclusions, regardless of clinical phenotype, age, or progression. Some lack vacuoles, challenging diagnosis. Discrepancies between clinical, neurophysiology, and biopsy findings should prompt consideration of VCP-MSP to improve detection and management.
UR - https://www.scopus.com/pages/publications/105011324457
U2 - 10.1212/NXG.0000000000200265
DO - 10.1212/NXG.0000000000200265
M3 - Article
C2 - 40678441
AN - SCOPUS:105011324457
SN - 2376-7839
VL - 11
JO - Neurology: Genetics
JF - Neurology: Genetics
IS - 4
M1 - e200265
ER -